Doctors track new kidney cancer drug duo in real patients
NCT ID NCT05361434
Summary
This study is observing how well the combination of cabozantinib and nivolumab works for adults with advanced kidney cancer in real-world medical settings. Researchers are following 311 patients who have already been prescribed this two-drug treatment as their first therapy. The goal is to collect information about how long patients live, how long the cancer stays controlled, side effects, and quality of life while receiving this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AOU San Luigi Gonzaga
Orbassano, Italy
-
ATTIKO University Hospital
Chaïdári, Greece
-
Akershus Universitetssykehus
Lørenskog, Norway
-
Belfast City Hospital
Belfast, United Kingdom
-
CH Dentellières
Valenciennes, France
-
CHU Charles Nicolle
Rouen, France
-
CHU Namur Mont-Godinne
Yvoir, Belgium
-
CHU St Pierre & Brugmann
Brussels, Belgium
-
Centre Finisterien de Radiotherapie et d'Oncologie
Brest, France
-
Centre Georges François Leclerc
Dijon, France
-
Centre Hospitalier Annecy Genevois
Épagny, France
-
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
-
Centre Hospitalier Fleyriat
Bourg-en-Bresse, France
-
Centre Hospitalier Régional D'orléans
Orléans, France
-
Centre Hospitalier Régional Universitaire de (CHRU) de Tours - Hôpital Bretonneau
Tours, France
-
Centre Hospitalier Régional Universitaire de Besançon - Jean Minjoz
Besançon, France
-
Centre Hospitalier Tenon
Paris, France
-
Centre Hospitalier Universitaire (CHU) Henri Mondor
Créteil, France
-
Centre Hospitalier Universitaire (CHU) de Angers
Angers, France
-
Centre Hospitalier Universitaire (CHU) de Nantes - Hôtel-Dieu
Nantes, France
-
Centre Hospitalier Universitaire (CHU) de Poitiers
Poitiers, France
-
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, France
-
Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied
Clermont-Ferrand, France
-
Centre Hospitalier de Boulogne-sur-mer
Boulogne-sur-Mer, France
-
Centre Hospitalier intercommunal Saint Raphaël Frejus
Fréjus, France
-
Centre d'Oncologie de l'Estuaire
Saint-Nazaire, France
-
Centre d'Urologie Site Médipole - Centre Catalan d'Urologie
Cabestany, France
-
Centre de Lutte Contre le Cancer Jean PERRIN
Clermont-Ferrand, France
-
Chonnam National University Hwasun Hospital
Jeongnam, South Korea
-
Clinique Mathilde Oncologie médicale
Rouen, France
-
Edinburgh Cancer Centre, Western General Hospital
Edinburgh, United Kingdom
-
Fondazione IRCCS, Istituto Nazionale dei Tumori
Milan, Italy
-
General Hospital of Athens Alexandra
Athens, Greece
-
Groupe Hospitalier De La Rochelle - Ré - Aunis
La Rochelle, France
-
Groupe Hospitalier Saint-André (Bordeaux)
Bordeaux, France
-
Henry Dunant Hospital
Athens, Greece
-
Hopital Bichat -Claud Bernard
Paris, France
-
Hopital Privé Jean Mermoz
Lyon, France
-
Hopital de Mercy- CHR Metz Thionville
Ars-Laquenexy, France
-
Hospital Foch - Oncology Service
Suresnes, France
-
Hospital Foch - Urology Service
Suresnes, France
-
Hôpital Européen Georges Pompidou (HEGP)
Paris, France
-
Hôpital Pitié-Salpétrière
Paris, France
-
Hôpital Privé Le Bois
Lille, France
-
ICANS - Institut de cancérologie Strasbourg Europe
Strasbourg, France
-
ICONE
Bezannes, France
-
IOV - Istituto Oncologico Veneto - IRCCS - Ospedale Busonera
Padua, Italy
-
Institut Bergonié
Bordeaux, France
-
Institut Ste Catherine - Institut du Cancer Avignon Provence
Avignon, France
-
Institut de Cancérologie de Bourgogne
Dijon, France
-
Institut de Cancérologie de Lorraine Alexis Vautrin
Vandœuvre-lès-Nancy, France
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Napoli, Italy
-
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", IRCCS - Oncologia
Meldola, Italy
-
Jessa Ziekenhuis
Hasselt, Belgium
-
King Abdulaziz Medical City - Jeddah
Jeddah, Saudi Arabia
-
King Abdulaziz Medical City- Riyadh
Riyadh, Saudi Arabia
-
Ospedale "Santa Maria delle Croci" di Ravenna
Ravenna, Italy
-
Ospedale Generale Provincial
Macerata, Italy
-
Ospedale San Camillo Forlanini
Roma, Italy
-
P.O Santa Maria delle Grazie, ASL Napoli 2 Nord
Pozzuoli, Italy
-
PU A.Gemelli, Università Cattolica del Sacro Cuore
Roma, Italy
-
Papageorgiou General Hosp of Thessaloniki
Thessaloniki, Greece
-
Policlinico Universitario Campus Biomedico
Roma, Italy
-
Samsung Medical Center
Seoul, South Korea
-
Seoul St Mary's Hospital
Seoul, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.